Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

US President Donald Trump signed a Presidential memo on reciprocal tariffs to order his administration to investigate the ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

The fund, with its quality characteristics, underperformed its benchmark for the quarter and the year. Read more here.

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...